Will Jnana Therapeutics' JNT-517 drug enter Phase 3 trials by June 30, 2025? | Binary | | | 5 months ago | |
Will Jnana Therapeutics achieve any milestone payments by December 31, 2025? | Binary | | | 5 months ago | |
Will Otsuka complete the acquisition of Jnana Therapeutics by December 31, 2024? | Binary | | | 5 months ago | |
Will Otsuka Pharmaceutical issue any milestone payments to Jnana Therapeutics by December 31, 2024? | Binary | | | 5 months ago | |
How much in milestone payments will Jnana Therapeutics achieve by December 31, 2025? | Categorical | | | 5 months ago | |
What will be the leadership status at Jnana Therapeutics by December 31, 2024? | Categorical | | | 5 months ago | |
What will be the next major therapeutic area Jnana will focus on post-acquisition by December 31, 2024? | Categorical | | | 5 months ago | |
What will be the key milestone achieved by Jnana Therapeutics under Otsuka's ownership by December 31, 2024? | Categorical | | | 5 months ago | |
Will Jnana Therapeutics' drug JNT-517 receive FDA approval for PKU by December 31, 2024? | Binary | | | 5 months ago | |
What will be the leadership change at Jnana Therapeutics post-acquisition by December 31, 2024? | Categorical | | | 5 months ago | |
What will be the performance outcome of Jnana Therapeutics' RAPID platform under Otsuka's ownership by December 31, 2024? | Categorical | | | 5 months ago | |
